Claudette Mallory
Family · Jacksonville, FLNPI 1679547442
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,119 and has fallen 83.4% since, to $186 in 2025.
Across 160 payments — averaging $19.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$677
- Hologic Sales And Service, LLC$633
- Novo Nordisk$208
- Evofem Biosciences, Inc.$189
- Bayer$170
- Organon$133
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,12098%
- Education$612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $677 |
| Hologic Sales And Service, LLC | 20 | $633 |
| Novo Nordisk | 12 | $208 |
| Evofem Biosciences, Inc. | 11 | $189 |
| Bayer | 11 | $170 |
| Organon | 9 | $133 |
| Astellas Pharma US Inc | 6 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $118 |
| Exeltis, USA Inc. | 3 | $104 |
| Mayne Pharma Commercial LLC | 4 | $91 |
| Therapeuticsmd, Inc. | 6 | $90 |
| Daiichi Sankyo Inc. | 5 | $81 |
| Myovant Sciences Inc. | 4 | $65 |
| Shield Therapeutics Inc | 3 | $60 |
| Vivus LLC | 3 | $58 |
| Pfizer | 3 | $55 |
| Biohaven Pharmaceuticals, Inc. | 3 | $54 |
| Agile Therapeutics, Inc. | 4 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Avion Pharmaceuticals | 2 | $31 |
| Coopersurgical, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $20 |
| BD | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Virtus Pharmaceuticals LLC | 1 | $14 |
| Davol Inc. | 1 | $13 |
| Scynexis, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aptima$141
How this compares
$3,181 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 12 | $449 |
| Ondansetron OdtOndansetron | 11 | $88 |
Paid to pharmacies, not to this prescriber.
Other family in Jacksonville
- Leighanne MeadeJacksonville$98K
- Jori TaylorJacksonville$48K
- Macy SaundersJacksonville$30K
- Amy KadlubowskiJacksonville$29K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.